AstraZeneca Pharma India Limited Stock Price

BSE:506820 Community·₹216.8b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create Narrative

506820 Share Price Performance

₹8,671.45

-644.20 (-6.92%)

₹8,671.45

-644.20 (-6.92%)

₹8,671.45

Sun, 31 May 26

Share Pricen/a

506820 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with solid track record.

2 Risks

1 Reward

View Full Analysis

AstraZeneca Pharma India Limited Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 75.01
: 39.33%
: 8.24%
: 0%

View Full Analysis

About 506820

Founded: 1979
Employees: 600
CEO: Praveen Akkinepally
WebsiteView website: www.astrazeneca.in

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.